GlassScriptPhysician profile
Michael J Mortensen
NPI 1679709273
$939.15
in general payments reported to CMS, 2019-2025
13 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $34.92 · 2021: $44.55 · 2022: $291 · 2023: $177 · 2024: $124 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412 · Education: $14.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.47 |
| Education | $14.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $141.29 | 2021-2025 | Minimed 780g |
| Abbvie INC. | $138.06 | 2022-2023 | |
| Alexion Pharmaceuticals, INC. | $137.02 | 2019-2023 | Strensiq |
| Abbott Laboratories | $132.01 | 2022-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Dexcom, INC. | $127.63 | 2022-2025 | Dexcom G6 Transmitter |
| Insulet Corporation | $91.29 | 2022-2025 | Omnipod |
| Tandem Diabetes Care, INC. | $58.17 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sequel Med Tech, LLC | $29.25 | 2025 | Twiist |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.32 | 2020 | |
| Janssen Pharmaceuticals, INC | $20.95 | 2019 | |
| Radius Health, INC. | $14.52 | 2023 | |
| Baxter Healthcare | $14.04 | 2023 | Floseal |
| Companion Medical, INC. | $12.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mortensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.